LRTOMT-NFIC Fusion FISH Probe
The LRTOMT-NFIC Fusion FISH Probe is used to confirm a fusion of the LRTOMT and NFIC genes. The fusion of the LRTOMT and NFIC genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
LRTOMT-NFIC-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-RERE | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-REOR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-REGO | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-REGR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-REAQ | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-ORRE | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-OROR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-ORGO | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-ORAQ | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GORE | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GOOR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GOGO | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GOGR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GOAQ | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GRRE | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GROR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GRGO | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GRGR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-GRAQ | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-AQRE | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-AQOR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-AQGO | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-AQGR | 20 (40 μL) | 200 μL | ||
LRTOMT-NFIC-20-AQAQ | 20 (40 μL) | 200 μL |
NFIC Gene Summary
The protein encoded by this gene belongs to the CTF/NF-I family. These are dimeric DNA-binding proteins, and function as cellular transcription factors and as replication factors for adenovirus DNA replication. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2011]
Gene Name: Nuclear Factor I C
Chromosome: CHR19: 3359615 -3463603
Locus: 19p13.3
LRTOMT Gene Summary
This gene has evolved in primates as a fusion of two ancestral neighboring genes, Lrrc51 and Tomt, which exist as two independent genes in rodents. The fusion gene contains some shared exons, but encodes structurally unrelated proteins, LRTOMT1 and LRTOMT2. Those variants that utilize the more centromere-proximal 3' terminal exon (short transcript form) encode LRTOMT1, while those variants that use a more centromere-distal 3' terminal exon (long transcript form) encode the LRTOMT2 protein. There is a small region within one of the exons of this gene that contains overlapping alternate reading frames for both LRTOMT1 and LRTOMT2. LRTOMT1 shares similarity with the protein encoded by mouse Lrrc51, while LRTOMT2 shares similarity with the protein encoded by mouse Tomt. Alternative splicing results in multiple transcript variants, encoding different isoforms of both LRTOMT1 and LRTOMT2. The LRTOMT1 protein is a leucine-rich repeat-containing protein, while the LRTOMT2 protein is a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols and is essential for auditory and vestibular function. Mutations in this gene have been associated with nonsyndromic deafness. [provided by RefSeq, Nov 2017]
Gene Name: Leucine Rich Transmembrane And O-methyltransferase Domain Containing
Chromosome: CHR11: 71791376 -71821828
Locus: 11q13.4
Gene Diseases
The LRTOMT NFIC Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|